CXCR4 and acute lymphoblastic leukemia: Overall, these results strongly indicate that the SDF-1/CXCR4 signaling pathway plays a crucial role in re-expansion of ALL leukemic cells in the hepatic niche after chemotherapy and provide a novel anti-leukemic therapy that targets the extramedullary microenvironment.